TY - JOUR
T1 - Shared structural mechanisms of alternating access between the secondary peptide transporter SbmA and ABC transporters
AU - Ettema, Thijs W.
AU - Inaba-Inoue, Satomi
AU - Thangaratnarajah, Chancievan
AU - Alves da Silva, Leticia
AU - Senning, Nikas
AU - Clarke, Amy
AU - Stepien, Piotr
AU - Shah, Anokhi
AU - Ma, Yue
AU - Hardman, Katie
AU - David, Sophia
AU - El Mkami, Hassane
AU - Heddle, Jonathan G.
AU - Nomura, Norimichi
AU - Ogasawara, Satoshi
AU - Iwata, So
AU - Ghilarov, Dmitry
AU - Pliotas, Christos
AU - Stockner, Thomas
AU - Slotboom, Dirk J.
AU - Beis, Konstantinos
N1 - Funding: Funding for this work was provided by: Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/H01778X/1 (K.B.), Japan Society for the Promotion of Science Overseas Fellowship and Grants-in-Aid for Scientific Research KAKENHI grants 24K08708 (S.I.-I.), the Bill & Melinda Gates Foundation (investment number INV-025280) (S.D.), Joint Usage/Research Center Program of the Institute for Life and Medical Sciences at Kyoto University (N.N.), AMED Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS, JP24ama121007) (N.N. and S.I.), Team program of the Foundation for Polish Science cofinanced by the European Union under the European Regional Development Fund TEAM/2016-3/23 (J.G.H. and P.S.). As part of the COFUND project oLife, C.T. acknowledges funding from the European Union’s Horizon 2020 research and innovation program under the Grant Agreement 847675. D.J.S. acknowledges funding from the Dutch Research Council: NWO TOP grant 714.018.003. EPR spectroscopy sample preparation and measurements were supported by BBSRC (BB/T006048/1, BB/S018069/1) awarded to C.P. and BB/W019795/1 awarded to C.P. and K.B. HEM thanks the Wellcome Trust for multi-user equipment grant (099149/Z/12/Z), and the equipment funding by BBSRC (BB/T017740/1) and BB/R013780/1). D.G. is a recipient of the Sir Henry Dale fellowship (221868/Z/20/Z) jointly funded by the Wellcome Trust and the Royal Society; work in his lab is also supported by the BBSRC-funded Institute Strategic Programme “Harnessing Biosynthesis for Sustainable Food and Health” (HBio) (grant number BB/X01097X/1). T.S. has received funding from the Austrian Science Fund (FWF) stand-alone grants P32017 and P34670 and from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no: 860954.
PY - 2026/6/29
Y1 - 2026/6/29
N2 - SbmA is a membrane transporter from Escherichia coli that imports antimicrobial peptides. SbmA belongs to the SbmA-like peptide transporter (SLiPT) family. Although the protein is a secondary active transporter that is energized by the proton gradient, it is structurally related to the transmembrane domain (TMD) of ATP-binding cassette (ABC) transporters. SbmA therefore bridges the structural divide between primary and secondary transporters. However, it remains unclear, if SbmA also shares the mechanism of alternating access with ABC transporters, because only a single (outward-open) state is resolved. Here, we show by sequence analysis that SbmA is likely evolved from the TMD of an early ancestor of the ABC transporter YddA. We determine the cryogenic electron microscopy structures of SbmA in occluded and inward-facing states. These conformations closely resemble equivalent states found in ABC transporters, indicating a shared structural mechanism of transport. In contrast to ABC transporters, where nucleotide binding, hydrolysis and release steer conformational changes necessary for substrate translocation, electron paramagnetic resonance (EPR) spectroscopy and molecular dynamics (MD) simulations reveal how pH changes induce conformational transitions in SbmA, consistent with a mechanism of substrate internalization that utilizes the transmembrane proton gradient.
AB - SbmA is a membrane transporter from Escherichia coli that imports antimicrobial peptides. SbmA belongs to the SbmA-like peptide transporter (SLiPT) family. Although the protein is a secondary active transporter that is energized by the proton gradient, it is structurally related to the transmembrane domain (TMD) of ATP-binding cassette (ABC) transporters. SbmA therefore bridges the structural divide between primary and secondary transporters. However, it remains unclear, if SbmA also shares the mechanism of alternating access with ABC transporters, because only a single (outward-open) state is resolved. Here, we show by sequence analysis that SbmA is likely evolved from the TMD of an early ancestor of the ABC transporter YddA. We determine the cryogenic electron microscopy structures of SbmA in occluded and inward-facing states. These conformations closely resemble equivalent states found in ABC transporters, indicating a shared structural mechanism of transport. In contrast to ABC transporters, where nucleotide binding, hydrolysis and release steer conformational changes necessary for substrate translocation, electron paramagnetic resonance (EPR) spectroscopy and molecular dynamics (MD) simulations reveal how pH changes induce conformational transitions in SbmA, consistent with a mechanism of substrate internalization that utilizes the transmembrane proton gradient.
U2 - 10.1038/s41467-026-71633-3
DO - 10.1038/s41467-026-71633-3
M3 - Article
C2 - 41986346
SN - 2041-1723
VL - 17
JO - Nature Communications
JF - Nature Communications
M1 - 5619
ER -